These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 22701689)

  • 1. Functional reconstitution of a tunable E3-dependent sumoylation pathway in Escherichia coli.
    O'Brien SP; DeLisa MP
    PLoS One; 2012; 7(6):e38671. PubMed ID: 22701689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SUMO conjugation - a mechanistic view.
    Pichler A; Fatouros C; Lee H; Eisenhardt N
    Biomol Concepts; 2017 Mar; 8(1):13-36. PubMed ID: 28284030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Vitro SUMOylation Assay to Study SUMO E3 Ligase Activity.
    Yang WS; Campbell M; Kung HJ; Chang PC
    J Vis Exp; 2018 Jan; (131):. PubMed ID: 29443041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of Protein Sumoylation.
    Sarge KD
    Curr Protoc Protein Sci; 2016 Feb; 83():14.8.1-14.8.8. PubMed ID: 26836406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SUMO-SIM interactions: From structure to biological functions.
    Lascorz J; Codina-Fabra J; Reverter D; Torres-Rosell J
    Semin Cell Dev Biol; 2022 Dec; 132():193-202. PubMed ID: 34840078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Fluorescent In Vitro Assay to Investigate Paralog-Specific SUMO Conjugation.
    Eisenhardt N; Chaugule VK; Pichler A
    Methods Mol Biol; 2016; 1475():67-78. PubMed ID: 27631798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanisms in SUMO conjugation.
    Varejão N; Lascorz J; Li Y; Reverter D
    Biochem Soc Trans; 2020 Feb; 48(1):123-135. PubMed ID: 31872228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SUMO-targeted ubiquitin ligases.
    Sriramachandran AM; Dohmen RJ
    Biochim Biophys Acta; 2014 Jan; 1843(1):75-85. PubMed ID: 24018209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reconstitution of the Recombinant RanBP2 SUMO E3 Ligase Complex.
    Ritterhoff T; Das H; Hao Y; Sakin V; Flotho A; Werner A; Melchior F
    Methods Mol Biol; 2016; 1475():41-54. PubMed ID: 27631796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small ubiquitin-like modifier (SUMO) modification of zinc finger protein 131 potentiates its negative effect on estrogen signaling.
    Oh Y; Chung KC
    J Biol Chem; 2012 May; 287(21):17517-17529. PubMed ID: 22467880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Casein kinase-2-mediated phosphorylation increases the SUMO-dependent activity of the cytomegalovirus transactivator IE2.
    Tripathi V; Chatterjee KS; Das R
    J Biol Chem; 2019 Oct; 294(40):14546-14561. PubMed ID: 31371453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical characterization of SUMO-conjugating enzymes by in vitro sumoylation assays.
    Eisenhardt N; Ilic D; Nagamalleswari E; Pichler A
    Methods Enzymol; 2019; 618():167-185. PubMed ID: 30850051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reconstitution of Arabidopsis thaliana SUMO pathways in E. coli: functional evaluation of SUMO machinery proteins and mapping of SUMOylation sites by mass spectrometry.
    Okada S; Nagabuchi M; Takamura Y; Nakagawa T; Shinmyozu K; Nakayama J; Tanaka K
    Plant Cell Physiol; 2009 Jun; 50(6):1049-61. PubMed ID: 19376783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional characterization of DnSIZ1, a SIZ/PIAS-type SUMO E3 ligase from Dendrobium.
    Liu F; Wang X; Su M; Yu M; Zhang S; Lai J; Yang C; Wang Y
    BMC Plant Biol; 2015 Sep; 15():225. PubMed ID: 26376625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ND10 Component Promyelocytic Leukemia Protein Acts as an E3 Ligase for SUMOylation of the Major Immediate Early Protein IE1 of Human Cytomegalovirus.
    Reuter N; Schilling EM; Scherer M; Müller R; Stamminger T
    J Virol; 2017 May; 91(10):. PubMed ID: 28250117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Circuitry of the SUMO (Small Ubiquitin-like Modifier) Pathway in Controlling Sumoylation Homeostasis and Suppressing Genome Rearrangements.
    de Albuquerque CP; Liang J; Gaut NJ; Zhou H
    J Biol Chem; 2016 Apr; 291(16):8825-35. PubMed ID: 26921322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human Regulatory Protein Ki-1/57 Is a Target of SUMOylation and Affects PML Nuclear Body Formation.
    Saito Â; Souza EE; Costa FC; Meirelles GV; Gonçalves KA; Santos MT; Bressan GC; McComb ME; Costello CE; Whelan SA; Kobarg J
    J Proteome Res; 2017 Sep; 16(9):3147-3157. PubMed ID: 28695742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PIASxα ligase enhances SUMO1 modification of PTEN protein as a SUMO E3 ligase.
    Wang W; Chen Y; Wang S; Hu N; Cao Z; Wang W; Tong T; Zhang X
    J Biol Chem; 2014 Feb; 289(6):3217-30. PubMed ID: 24344134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SIM-dependent enhancement of substrate-specific SUMOylation by a ubiquitin ligase in vitro.
    Parker JL; Ulrich HD
    Biochem J; 2014 Feb; 457(3):435-40. PubMed ID: 24224485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control of nuclear activities by substrate-selective and protein-group SUMOylation.
    Jentsch S; Psakhye I
    Annu Rev Genet; 2013; 47():167-86. PubMed ID: 24016193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.